37 related articles for article (PubMed ID: 25155283)
1. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Han W; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; Shi CT; Ding HZ
PLoS One; 2016; 11(1):e0145803. PubMed ID: 26731428
[TBL] [Abstract][Full Text] [Related]
2. Osteonectin (SPARC) prognostic value in prostate cancer.
Chekhun V; Borikun T; Zadvornyi T; Mushii O; Stakhovsky E; Vitruk Y; Lukianova N
Pathol Res Pract; 2024 Feb; 254():155053. PubMed ID: 38199134
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of lung recurrence in patients with biliary tract cancer.
Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of SPARC expression in gastric cancer: a meta-analysis.
Wang Z; Hao B; Yang Y; Wang R; Li Y; Wu Q
Arch Med Sci; 2014 Oct; 10(5):863-9. PubMed ID: 25395936
[TBL] [Abstract][Full Text] [Related]
5. Serum protein acidic and rich in cysteine (SPARC) as a prognostic marker in soft tissue sarcomas.
Morgan SS; Nagle RB; Cranmer LD
Clin Sarcoma Res; 2014 Jan; 4(1):2. PubMed ID: 24484617
[TBL] [Abstract][Full Text] [Related]
6. A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).
Kanai M; Hatano E; Kobayashi S; Fujiwara Y; Marubashi S; Miyamoto A; Shiomi H; Kubo S; Ikuta S; Yanagimoto H; Terajima H; Ikoma H; Sakai D; Kodama Y; Seo S; Morita S; Ajiki T; Nagano H; Ioka T
Cancer Chemother Pharmacol; 2015 Feb; 75(2):293-300. PubMed ID: 25477010
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of secreted protein acidic and rich in cysteine in patients with solid tumors.
Ma Y; Chen H; Ma H; Yao Z; Hu J; Ma J; Zhang X; Chen G; Liu Y
Saudi Med J; 2019 Aug; 40(8):755-765. PubMed ID: 31423511
[TBL] [Abstract][Full Text] [Related]
8. High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.
Nakajima M; Yoshino S; Kanekiyo S; Maeda N; Sakamoto K; Tsunedomi R; Suzuki N; Takeda S; Yamamoto S; Hazama S; Hoshii Y; Oga A; Itoh H; Ueno T; Nagano H
Oncol Lett; 2018 Jan; 15(1):803-812. PubMed ID: 29403557
[TBL] [Abstract][Full Text] [Related]
9. Smoc2 potentiates proliferation of hepatocellular carcinoma cells
Su JR; Kuai JH; Li YQ
World J Gastroenterol; 2016 Dec; 22(45):10053-10063. PubMed ID: 28018113
[TBL] [Abstract][Full Text] [Related]
10. Impact of Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression on Prognosis After Surgical Resection for Biliary Carcinoma.
Toyota K; Murakami Y; Kondo N; Uemura K; Nakagawa N; Takahashi S; Sueda T
J Gastrointest Surg; 2017 Jun; 21(6):990-999. PubMed ID: 28342122
[TBL] [Abstract][Full Text] [Related]
11. SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
Takayama H; Kobayashi S; Gotoh K; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Asaoka T; Noda T; Wada H; Takahashi H; Tanemura M; Doki Y; Eguchi H
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10935-10950. PubMed ID: 37330435
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells.
Aghamaliyev U; Gaitantzi H; Thomas M; Simon-Keller K; Gaiser T; Marx A; Yagublu V; Araos J; Cai C; Valous NA; Halama N; Kiesslich T; Ebert M; Grützmann R; Rückert F; Breitkopf-Heinlein K
Eur Surg Res; 2019; 60(1-2):1-12. PubMed ID: 30650425
[TBL] [Abstract][Full Text] [Related]
13. A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.
Clark CJ; Sage EH
J Cell Biochem; 2008 Jun; 104(3):721-32. PubMed ID: 18253934
[TBL] [Abstract][Full Text] [Related]
14. Stromal expression of SPARC in pancreatic adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Cros J; Faivre S; Hammel P; Raymond E
Cancer Metastasis Rev; 2013 Dec; 32(3-4):585-602. PubMed ID: 23690170
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer.
Nakashima S; Kobayashi S; Sakai D; Tomokuni A; Tomimaru Y; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Matsuura N; Doki Y; Mori M; Nagano H
J Surg Oncol; 2014 Dec; 110(8):1016-22. PubMed ID: 25155283
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
